In: Erdman JWJ, Macdonald IA, Zeisel SH, eds
Tirzepatide This tirzepatide program is built for adults seeking medically supervised weight loss, typically those with a BMI of 27 or higher
Adapting your at-home oral care routine, such as brushing after each meal and using a mouth rinse, can offset some symptoms before they progress
Retatrutide: A Promising Option for Non-Diabetic Weight Loss in Clinical Trials Key Takeaways Retatrutide, a new triple receptor agonist, appears particularly promising as a non-diabetic weight loss agent because it targets glucagon, GLP-1, and GIP
Accordingly, the participant was included in the safety analysis set but excluded from the efficacy and PK analysis sets